⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Ledande inom antikroppsbaserad behandling mot IL1RAP just got measured.
4/10 means Ledande inom antikroppsbaserad behandling mot IL1RAP is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för behandling av såväl cancer som autoimmuna och inflammatoriska sjukdomar.
Industry: Technology
cantargia.com1
Structured Data
6
Content Structure
5
Entity Clarity
3
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Ledande inom antikroppsbaserad behandling mot IL1RAP.
Scored by Engagemii on July 1, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/cantargia
Cite this score: Engagemii (2026). "AEO Score for Ledande inom antikroppsbaserad behandling mot IL1RAP." Retrieved from https://engagemii.com/aeo/brands/cantargia
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform